PRKN and Parkinson disease: Mutations in LRRK2, PARK2, and PINK‐1 are associated with mitochondria‐dependent apoptosis in vitro and in murine models of PD, through p53 activation (Ho, Seol, & Son, 2019), cytochrome c release, and caspase activation (Iaccarino et al., 2007).